Home The History of Synthetic Biology Designing Synthetic Biotics Pipeline Our People Leadership Board of Directors Founders and Advisors Investors + Media Company Overview News News Releases In the News Events & Presentations Events Presentations Publications Stock Information Stock Quote & Chart Analyst Coverage Corporate Governance Governance Highlights Management Team Board of Directors Committee Composition Board Diversity Matrix Financials Quarterly Results Investor Resources FAQs Contact IR Email Alerts RSS Feeds Ed Arce Ed Arce H.C. Wainwright & Co earce@hcwco.com Synlogic Presents Clinical and Preclinical Data from Synthetic Biotic™ Medicine Programs for Treatment of Inborn Errors of Metabolism at Annual Meeting of The Society for Inherited Metabolic Disorders Read more about Synlogic Presents Clinical and Preclinical Data from Synthetic Biotic™ Medicine Programs for Treatment of Inborn Errors of Metabolism at Annual Meeting of The Society for Inherited Metabolic Disorders Synlogic to Webcast Presentation at the Cowen and Company 38th Annual Health Care Conference Read more about Synlogic to Webcast Presentation at the Cowen and Company 38th Annual Health Care Conference Synlogic Presents Data from Immuno-Oncology Development Program Demonstrating Potent Anti-Tumor Immunity Following Administration of Novel STING Agonist-producing Synthetic Biotic™ Medicine Read more about Synlogic Presents Data from Immuno-Oncology Development Program Demonstrating Potent Anti-Tumor Immunity Following Administration of Novel STING Agonist-producing Synthetic Biotic™ Medicine Synlogic to Present at the Leerink Partners 7th Annual Global Healthcare Conference Read more about Synlogic to Present at the Leerink Partners 7th Annual Global Healthcare Conference Synlogic Announces Underwriters’ Option Exercise in Full Read more about Synlogic Announces Underwriters’ Option Exercise in Full Synlogic Announces Pricing of Public Offering of Common Stock Read more about Synlogic Announces Pricing of Public Offering of Common Stock Synlogic Announces Proposed Public Offering of Common Stock Read more about Synlogic Announces Proposed Public Offering of Common Stock Synlogic Progresses Clinical and Preclinical Pipeline and Outlines 2018 Catalysts Read more about Synlogic Progresses Clinical and Preclinical Pipeline and Outlines 2018 Catalysts Synlogic and Ginkgo Bioworks Announce Collaboration as First Step Toward Building an Unprecedented Discovery Engine for Novel Living Medicines in Neurological and Liver Disorders Read more about Synlogic and Ginkgo Bioworks Announce Collaboration as First Step Toward Building an Unprecedented Discovery Engine for Novel Living Medicines in Neurological and Liver Disorders Pagination First page « First Previous page ‹ Previous … Page 16 Page 17 Page 18 Page 19 Current page 20 Page 21 Page 22 Page 23 Page 24 Next page Next › Last page Last » Subscribe to Investor Resources Contact IR Investor FAQs RSS Feeds Investor Email Alerts Email
Synlogic Presents Clinical and Preclinical Data from Synthetic Biotic™ Medicine Programs for Treatment of Inborn Errors of Metabolism at Annual Meeting of The Society for Inherited Metabolic Disorders Read more about Synlogic Presents Clinical and Preclinical Data from Synthetic Biotic™ Medicine Programs for Treatment of Inborn Errors of Metabolism at Annual Meeting of The Society for Inherited Metabolic Disorders
Synlogic to Webcast Presentation at the Cowen and Company 38th Annual Health Care Conference Read more about Synlogic to Webcast Presentation at the Cowen and Company 38th Annual Health Care Conference
Synlogic Presents Data from Immuno-Oncology Development Program Demonstrating Potent Anti-Tumor Immunity Following Administration of Novel STING Agonist-producing Synthetic Biotic™ Medicine Read more about Synlogic Presents Data from Immuno-Oncology Development Program Demonstrating Potent Anti-Tumor Immunity Following Administration of Novel STING Agonist-producing Synthetic Biotic™ Medicine
Synlogic to Present at the Leerink Partners 7th Annual Global Healthcare Conference Read more about Synlogic to Present at the Leerink Partners 7th Annual Global Healthcare Conference
Synlogic Announces Underwriters’ Option Exercise in Full Read more about Synlogic Announces Underwriters’ Option Exercise in Full
Synlogic Announces Pricing of Public Offering of Common Stock Read more about Synlogic Announces Pricing of Public Offering of Common Stock
Synlogic Announces Proposed Public Offering of Common Stock Read more about Synlogic Announces Proposed Public Offering of Common Stock
Synlogic Progresses Clinical and Preclinical Pipeline and Outlines 2018 Catalysts Read more about Synlogic Progresses Clinical and Preclinical Pipeline and Outlines 2018 Catalysts
Synlogic and Ginkgo Bioworks Announce Collaboration as First Step Toward Building an Unprecedented Discovery Engine for Novel Living Medicines in Neurological and Liver Disorders Read more about Synlogic and Ginkgo Bioworks Announce Collaboration as First Step Toward Building an Unprecedented Discovery Engine for Novel Living Medicines in Neurological and Liver Disorders